These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26762524)

  • 1. Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial.
    Peralta CA; McClure LA; Scherzer R; Odden MC; White CL; Shlipak M; Benavente O; Pergola P
    Circulation; 2016 Feb; 133(6):584-91. PubMed ID: 26762524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes ( SPS 3) Trial.
    Ikeme JC; Pergola PE; Scherzer R; Shlipak MG; Catanese L; McClure LA; Benavente OR; Peralta CA
    J Am Heart Assoc; 2019 Feb; 8(3):e010091. PubMed ID: 30686103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Baseline Kidney Function on the Risk of Recurrent Stroke and on Effects of Intensive Blood Pressure Control in Patients With Previous Lacunar Stroke: A Post Hoc Analysis of the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).
    Agarwal A; Cheung AK; Ma J; Cho M; Li M
    J Am Heart Assoc; 2019 Aug; 8(16):e013098. PubMed ID: 31423869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieved Blood Pressure and Outcomes in the Secondary Prevention of Small Subcortical Strokes Trial.
    Odden MC; McClure LA; Sawaya BP; White CL; Peralta CA; Field TS; Hart RG; Benavente OR; Pergola PE
    Hypertension; 2016 Jan; 67(1):63-9. PubMed ID: 26553236
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Ikeme JC; Pergola PE; Scherzer R; Shlipak MG; Benavente OR; Peralta CA
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1040-1047. PubMed ID: 28446537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial.
    Pearce LA; McClure LA; Anderson DC; Jacova C; Sharma M; Hart RG; Benavente OR;
    Lancet Neurol; 2014 Dec; 13(12):1177-85. PubMed ID: 25453457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should Blood Pressure Targets After Lacunar Stroke Vary by Body Size? The SPS3 Trial.
    Field TS; McClure LA; White CL; Pergola PE; Hart RG; Benavente OR; Hill MD;
    Am J Hypertens; 2015 Jun; 28(6):756-64. PubMed ID: 25452300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial Estimated Glomerular Filtration Rate Decline and Long-Term Renal Function During Intensive Antihypertensive Therapy: A Post Hoc Analysis of the SPRINT and ACCORD-BP Randomized Controlled Trials.
    Collard D; Brouwer TF; Olde Engberink RHG; Zwinderman AH; Vogt L; van den Born BH
    Hypertension; 2020 May; 75(5):1205-1212. PubMed ID: 32223381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of mortality in patients with lacunar stroke in the secondary prevention of small subcortical strokes trial.
    Sharma M; Pearce LA; Benavente OR; Anderson DC; Connolly SJ; Palacio S; Coffey CS; Hart RG
    Stroke; 2014 Oct; 45(10):2989-94. PubMed ID: 25158772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPS3 Evidence Supports Intensive Blood Pressure Control.
    Oparil S
    Circulation; 2016 Feb; 133(6):552-4. PubMed ID: 26762523
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria:
    Chang AR; Kramer H; Wei G; Boucher R; Grams ME; Berlowitz D; Bhatt U; Cohen DL; Drawz P; Punzi H; Freedman BI; Haley W; Hawfield A; Horwitz E; McLouth C; Morisky D; Papademetriou V; Rocco MV; Wall B; Weiner DE; Zias A; Beddhu S;
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1121-1128. PubMed ID: 32669306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Intensive Blood Pressure Control on Kidney Outcomes: Long-Term Electronic Health Record-Based Post-Trial Follow-Up of SPRINT.
    Drawz PE; Lenoir KM; Rai NK; Rastogi A; Chu CD; Rahbari-Oskoui FF; Whelton PK; Thomas G; McWilliams A; Agarwal AK; Suarez MM; Dobre M; Powell J; Rocco MV; Lash JP; Oparil S; Raj DS; Dwyer JP; Rahman M; Soman S; Townsend RR; Pemu P; Horwitz E; Ix JH; Tuot DS; Ishani A; Pajewski NM
    Clin J Am Soc Nephrol; 2024 Feb; 19(2):213-223. PubMed ID: 37883184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacunar strokes in patients with diabetes mellitus: risk factors, infarct location, and prognosis: the secondary prevention of small subcortical strokes study.
    Palacio S; McClure LA; Benavente OR; Bazan C; Pergola P; Hart RG
    Stroke; 2014 Sep; 45(9):2689-94. PubMed ID: 25034716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study.
    Elkind MS; Luna JM; McClure LA; Zhang Y; Coffey CS; Roldan A; Del Brutto OH; Pretell EJ; Pettigrew LC; Meyer BC; Tapia J; White C; Benavente OR;
    Stroke; 2014 Mar; 45(3):707-16. PubMed ID: 24523037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial.
    ; Benavente OR; Coffey CS; Conwit R; Hart RG; McClure LA; Pearce LA; Pergola PE; Szychowski JM
    Lancet; 2013 Aug; 382(9891):507-15. PubMed ID: 23726159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory Markers and Outcomes After Lacunar Stroke: Levels of Inflammatory Markers in Treatment of Stroke Study.
    Boehme AK; McClure LA; Zhang Y; Luna JM; Del Brutto OH; Benavente OR; Elkind MS
    Stroke; 2016 Mar; 47(3):659-67. PubMed ID: 26888535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions.
    Shoamanesh A; Pearce LA; Bazan C; Catanese L; McClure LA; Sharma M; Marti-Fabregas J; Anderson DC; Kase CS; Hart RG; Benavente OR;
    Ann Neurol; 2017 Aug; 82(2):196-207. PubMed ID: 28681535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASA failure: does the combination ASA/clopidogrel confer better long-term vascular protection?
    Côté R; Zhang Y; Hart RG; McClure LA; Anderson DC; Talbert RL; Benavente OR
    Neurology; 2014 Feb; 82(5):382-9. PubMed ID: 24384643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Blood Pressure Changes and Kidney Function Decline in Persons Without Chronic Kidney Disease: Findings From the MESA Study.
    Judson GL; Rubinsky AD; Shlipak MG; Katz R; Kramer H; Jacobs DR; Odden MC; Peralta CA
    Am J Hypertens; 2018 Apr; 31(5):600-608. PubMed ID: 29036269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated glomerular filtration rate and the risk-benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial.
    Obi Y; Kalantar-Zadeh K; Shintani A; Kovesdy CP; Hamano T
    J Intern Med; 2018 Mar; 283(3):314-327. PubMed ID: 29044764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.